NCT03523338 2025-12-10An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate CancerAragon Pharmaceuticals, Inc.No longer available
NCT03554434 2020-03-02An Expanded Access Program for AM0010 (Pegilodecakin)Eli Lilly and CompanyNo longer available
NCT01516762 2014-07-14Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesBayerNo longer available
NCT00636259 2008-06-11Casodex 150-mg Compassionate Use Trial for Subjects With Prostate CancerAstraZenecaNo longer available